This year the College offers a series of pre-recorded virtual press briefings which feature the insights of leading gastroenterology experts on several key abstracts that will be unveiled at ACG 2014 in the areas related to hepatitis C, inflammatory bowel disease, drug induced liver injury, nonalcoholic fatty liver disease, fecal microbiota transplantation and C. difficile. Notable case reports related to protein shakes, chia seeds, and other supplementation where good health intentions go bad are also featured. In these briefings, ACG experts offer their perspectives on the significance of the findings in relation to the larger issues surrounding these GI-related topics as well as tips for clinicians and patients. Links to author commentary and the abstracts are available on this page for each abstract featured in the briefings.


John R. Saltzman, MD, FACG
John R. Saltzman, MD, FACG

ACG 2014 Highlights – Overview

John R. Saltzman, MD, FACG, Chair of the ACG Educational Affairs Committee, offers his insight on ACG 2014’s most groundbreaking research, educational sessions and must-see lecture  in this virtual press briefing.

Listen now

 

 


 

Hepatitis C (HCV)

David E. Bernstein, MD, FACG
David E. Bernstein, MD, FACG
Paul Y. Kwo, MD, FACG
Paul Y. Kwo, MD, FACG

David E. Bernstein, MD, FACG and Paul Y. Kwo, MD, FACG provide insight on the following abstracts:

Oral 4 SVR12 of 99% Achieved With a Ribavirin-Free Regiment of ABT-450r Ombitasvir and Dasabuvir in HCV Genotype 1b-Infected Patients
Read author insight and access abstract

Oral 5 Normalization of Liver-Related Laboratory Parameters in HCV Genotype 1-Infected Patients With  Cirrhosis After Treatment With ABT -450/R/Ombitasvir, Dasabuvir and Ribavirin
Read author insight and access abstract

Listen to the briefing


Russell D. Cohen, MD, FACG
Russell D. Cohen, MD, FACG

Inflammatory Bowel Disease (IBD)

Russell Cohen, MD, FACG, provides insight on the following abstracts:

P454 Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Patients With Inflammatory Bowel Disease
Read author insight and access abstract

Oral 61 Association of Mean Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Prospective Study
Read author insight and access abstract

P1654 Pediatric Crohn’s Disease, Unrealized Height and Diminished Lifetime Earnings
Read author insight and access abstract

P573 A Randomized, Controlled Trial of Yoga in Pediatric Inflammatory Bowel Disease: Preliminary Findings
Read author insight and access abstract

Listen to the briefing

 


Mark Mellow, MD, FACG
Mark Mellow, MD, FACG

Fecal Microbiota Transplantation (FMT) and C. difficile

Mark Mellow, MD, FACG, provides insight on the following abstracts:

Oral 72 Fresh, Frozen, or Lyophilized Fecal Microbiota Transplantation (FMT) for Multiple Recurrent C. difficile Infection (CDI)
Read author insight and access abstract

Poster 939 Safety Outcomes After Fecal Microbiota Transplantation (FMT) For C. difficile Infection (CDI)
Read author insight and access abstract

Oral 71 C. difficile Associated Risk of Death Score (CARDS): A Novel Risk Score to Predict Mortality Among Hospitalized Patients With C. difficile Infection
Read author insight and access abstract

Poster 1639 Fecal Microbiota Transplant for Treatment of Refractory C. difficile Colitis: Long-Term Follow-Up of 58 Patients
Read author insight and access abstract

Listen to the briefing


James Lewis, MD, FACG
James Lewis, MD, FACG

Drug Induced Liver Injury and Non-Alcoholic Fatty Liver Disease (NAFLD)

James Lewis, MD, FACG provides insight on the following abstracts

Oral 28 Association Between Aspirin Use and Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study From the Third National Health and Nutrition Examination Survey
Read author insight and access abstract

Oral 31 Idiosyncratic Drug-Induced Liver Injury (DILI) in the United States: A Report of 1,257 Prospectively Enrolled Patients
Read author insight and access abstract

Poster 1441 Association Between Caffeine Consumption and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis
Read author insight and access abstract

Listen to the briefing

Access the ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury


Patricia Raymond, MD, FACG
Patricia Raymond, MD, FACG

Health No Nos

Patricia Raymond, MD, FACG  provides insight on these notable case reports related to protein shakes, chia seeds, and other supplementation where good health intentions go bad:

Poster 280 First Case of Fatal Renal and Fulminant Hepatic Failure from Muscle Building Supplements
Read author insight and access abstract

Poster 643 Watch It Grow: Esophageal Impaction With Chia Seeds
Read author insight and access abstract

Poster 1296 Protein Shakes: An Unusual Cause of Gastric Phytobezoar in a Health Obsessed Person
Read author insight and access abstract

Poster1579 Getting Burned by Activated Charcoal: A Case of Colitis Associated With Activated Charcoal Use
Read author insight and access abstract

Poster 369 Supplement-Induced Acute Colonic Pseudo-Obstruction in Healthy Young Male
Read author insight and access abstract

Poster 1261 Desiccant-Induced Esophageal Obstruction: An Emerging Patient Safety Issue
Read author insight and access abstract

Listen to the briefing


 Media Interview Requests:

To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email jgaulin@gi.org or by phone at 301-263-9000.